Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 568

The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.

Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology

Abu-Rustum, Nadeem, Yashar, Catheryn, Arend, Rebecca, Barber, Emma, Bradley, Kristin, Brooks, Rebecca, Campos, Susana M., Chino, Junzo, Chon, Hye Sook, Chu, Christina, Crispens, Marta Ann, Damast, Shari, Fisher, Christine M., Frederick, Peter, Gaffney, David K., Giuntoli, Robert, Han, Ernest, Holmes, Jordan, Howitt, Brooke E., Lea, Jayanthi, Mariani, Andrea, Mutch, David, Nagel, Christa, Nekhlyudov, Larissa, Podoll, Mirna, Salani, Ritu, Schorge, John, Siedel, Jean, Sisodia, Rachel, Soliman, Pamela, Ueda, Stefanie, Urban, Renata, Wethington, Stephanie L., Wyse, Emily, Zanotti, Kristine, McMillian, Nicole R., Aggarwal, Shaili·2023·Journal of the National Comprehensive Cancer Network

Abstract

Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. It is estimated that 65,950 new uterine cancer cases will have occurred in 2022, with 12,550 deaths resulting from the disease. Endometrial carcinoma includes pure endometrioid cancer and carcinomas with high-risk endometrial histology (including uterine serous carcinoma, clear cell carcinoma, carcinosarcoma [also known as malignant mixed Müllerian tumor], and undifferentiated/dedifferentiated carcinoma). Stromal or mesenchymal sarcomas are uncommon subtypes accounting for approximately 3% of all uterine cancers. This selection from the NCCN Guidelines for Uterine Neoplasms focuses on the diagnosis, staging, and management of pure endometrioid carcinoma. The complete version of the NCCN Guidelines for Uterine Neoplasms is available online at NCCN.org.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2023.0006

Cites

154 of 154 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 154 references

Cited by

See all 568

Metadata

Authors
Abu-Rustum, N., Yashar, C., Arend, R., Barber, E., Bradley, K., Brooks, R., Campos, S. M., Chino, J., Chon, H. S., Chu, C., Crispens, M. A., Damast, S., Fisher, C. M., Frederick, P., Gaffney, D. K., Giuntoli, R., Han, E., Holmes, J., Howitt, B. E., Lea, J., Mariani, A., Mutch, D., Nagel, C., Nekhlyudov, L., Podoll, M., Salani, R., Schorge, J., Siedel, J., Sisodia, R., Soliman, P., Ueda, S., Urban, R., Wethington, S. L., Wyse, E., Zanotti, K., McMillian, N. R., & Aggarwal, S.
Venue
Journal of the National Comprehensive Cancer Network
Published
2023-02
Volume
21
Issue
2
Pages
181-209
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
OpenAlex
W4320932489
Cited by
568
References
154
FWCI
152.72
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. https://app.cochat.ai/papers/10.6004/jnccn.2023.0006
The paper
Abu-Rustum, N., Yashar, C., Arend, R., Barber, E., Bradley, K., Brooks, R., Campos, S. M., Chino, J., Chon, H. S., Chu, C., Crispens, M. A., Damast, S., Fisher, C. M., Frederick, P., Gaffney, D. K., Giuntoli, R., Han, E., Holmes, J., Howitt, B. E., . . . Aggarwal, S. (2023). Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2023.0006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.